Purdue Pharma's patent for OxyContin expired Tuesday, opening up the opioid painkiller to generic competition, but authorities have raised concerns about what they call the potential for generic versions to be abused.
The Food and Drug Administration will not approve generic versions of Purdue Pharma's painkiller OxyContin based on earlier versions of the drug that did not include features to thwart abuse, the agency said.
Frito-Lay, a division of PepsiCo, announced this week the company is introducing completely "re-imagined" packaging across its Lay's Wavy brand line of chips and is adding a new garlic-flavored chip to the lineup.
No longer will the SymphonyIRI Group crunch data for the betterment of CPG companies everywhere, the company's president and CEO Andrew Appel told a packed conference room at the data aggregator's 2013 Summit. At least not as SymphonyIRI Group.
Online retailer Amazon has announced the launch of its new 50+ Active and Healthy Living Store, which features hundreds of thousands of nutrition, wellness, exercise and fitness, medical, personal care, beauty, entertainment items and more — all in a single destination for customers in the 50+ age range.
The Convenient Care Association and Drug Store News have announced the agenda for the Executive and Health Systems Leadership Colloquium for this year’s Retail Clinician Education Congress, which will be held in May in Las Vegas.
Generic makers heralded the fiscal year 2014 budget proposed last week by the Obama administration for its embrace of generic drugs, but were critical of its provisions on patent settlements and rebates.
Kool-Aid, a Kraft Foods brand, announced the launch of a new multimedia campaign to reintroduce the company's iconic Kool-Aid Man "spokespitcher" that will coincide with the release of a new liquid drink mix available on store shelves now.